InvestorsHub Logo
Followers 25
Posts 2531
Boards Moderated 0
Alias Born 10/26/2003

Re: DonDonDonDon post# 34178

Thursday, 11/11/2021 12:07:14 AM

Thursday, November 11, 2021 12:07:14 AM

Post# of 42801

We could get approval in the UK any day and might get approval in the US within a few months. An approval in Europe might also come quickly. Humanigen doesn't really have to do anything more except fill out some applications and wait. The ACTIV-5 trial is paid for. Have you seen the multi-billion dollar contracts that the newly approved Covid drugs are receiving?

Oh Donny Boy... Trying to pump-up your losing HGEN position?

HGEN has no production. None. Zippo. Zero. Nothing. Yet, because others are getting multi-billion dollar contracts you think the UK, Europe or the U.S. is going to approve Lenz that has no production and at best can produce 100k treatments in the next 12 months, which costs a ridiculous amount to produce per treatment and shows marginable benefits at best?

Let's get back in reality boys and girls...

Vaccine rates have moved up significantly and continue to move substantially higher as children become vaccinated, booster shots for adults are and continue to become more readily available (and are dirty cheap) and thus, herd immunity will be here in no time. Throw in PFE's Paxlovid Antiviral drug and the need for Lenz falls by the second.

Lenz might be used to treat Covid for decades.

Yeah, not going to happen, but good idea in trying to create some long-term value in your financial model.